MENU
SMRI
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Mid-Cap Value
SMRI
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for SMRI with price predictions
Oct 01, 2026

SMRI in downward trend: 10-day moving average moved below 50-day moving average on September 28, 2026

The 10-day moving average for SMRI crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMRI as a result. In 25 of 45 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 56%.

The Moving Average Convergence Divergence Histogram (MACD) for SMRI turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 31 similar instances when the indicator turned negative. In 17 of the 31 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.

SMRI moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SMRI's RSI Oscillator exited the oversold zone, 7 of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMRI advanced for three days, in 179 of 209 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

SMRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 194 of 235 cases where SMRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Merck & Co (NYSE:MRK), Salesforce (NYSE:CRM), ConocoPhillips (NYSE:COP), Newmont Corp (NYSE:NEM), Valero Energy Corp (NYSE:VLO), MARATHON PETROLEUM Corp (NYSE:MPC), Accenture PLC (NYSE:ACN), Phillips 66 (NYSE:PSX), Adobe (NASDAQ:ADBE), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF (SMRI) ETF is 87.26B. The market cap for tickers in the group ranges from 12.49B to 366.84B. MRK holds the highest valuation in this group at 366.84B. The lowest valued company is GEN at 12.49B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF (SMRI) ETF was 14%. For the same ETF, the average monthly price growth was 25%, and the average quarterly price growth was 145%. ACN experienced the highest price growth at 20%, while REGN experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF (SMRI) ETF was 7%. For the same stocks of the ETF, the average monthly volume growth was 22% and the average quarterly volume growth was -12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 46
Price Growth Rating: 47
SMR Rating: 50
Profit Risk Rating: 55
Seasonality Score: 29 (-100 ... +100)
View a ticker or compare two or three
SMRI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapValue

Category
Mid-Cap Value
Address
Alpha Architect ETF Trust213 Foxcroft Road, Broomall, PennsylvaniaBroomall
Phone
N/A
Web
www.valueshares.com
SMRI in downward trend: 10-day moving average moved below 50-day moving average on September 28, 2026